Amendment - 1st Reading/2nd House-blue - Requested by: Vince Ricci - (H) Business and
Labor
- 2025
69th Legislature 2025 Drafter: Jameson Walker, SB0447.002.001
1 SENATE BILL NO. 447
2 INTRODUCED BY V. RICCI, C. SCHOMER, C. HINKLE, J. ETCHART, L. DEMING, J. KARLEN
3
4 A BILL FOR AN ACT ENTITLED: “AN ACT REVISING LAWS RELATED TO PRIOR AUTHORIZATION;
5 EXTENDING THE LENGTH OF A PRIOR AUTHORIZATION CERTIFICATION; PROVIDING THAT A PRIOR
6 AUTHORIZATION FOR TREATMENT OF A CHRONIC CONDITION IS VALID FOR THE DURATION OF THE
7 CONDITION; PROHIBITING PRIOR AUTHORIZATION FOR CERTAIN PRESCRIPTIONS; PROVIDING
8 DEFINITIONS; AND AMENDING SECTIONS 33-32-102, 33-32-107, AND 33-32-221, MCA.”
9
10 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MONTANA:
11
12 Section 1. Section 33-32-102, MCA, is amended to read:
13 "33-32-102. Definitions. As used in this chapter, the following definitions apply:
14 (1) "Adverse determination", except as provided in 33-32-402, means:
15 (a) a determination by a health insurance issuer or its designated utilization review organization
16 that, based on the provided information and after application of any utilization review technique, a requested
17 benefit under the health insurance issuer's health plan is denied, reduced, or terminated or that payment is not
18 made in whole or in part for the requested benefit because the requested benefit does not meet the health
19 insurance issuer's requirement for medical necessity, appropriateness, health care setting, level of care, or level
20 of effectiveness or is determined to be experimental or investigational;
21 (b) a denial, reduction, termination, or failure to provide or make payment in whole or in part for a
22 requested benefit based on a determination by a health insurance issuer or its designated utilization review
23 organization of a person's eligibility to participate in the health insurance issuer's health plan;
24 (c) any prospective review or retrospective review of a benefit determination that denies, reduces,
25 or terminates or fails to provide or make payment in whole or in part for a benefit; or
26 (d) a rescission of coverage determination.
27 (2) "Ambulatory review" means a utilization review of health care services performed or provided in
- 1 - Authorized Print Version – SB 447

Amendment - 1st Reading/2nd House-blue - Requested by: Vince Ricci - (H) Business and
Labor
- 2025
69th Legislature 2025 Drafter: Jameson Walker, SB0447.002.001
1 an outpatient setting.
2 (3) "Authorized representative" means:
3 (a) a person to whom a covered person has given express written consent to represent the
4 covered person;
5 (b) a person authorized by law to provided substituted consent for a covered person; or
6 (c) a family member of the covered person, or the covered person's treating health care provider,
7 only if the covered person is unable to provide consent.
8 (4) "Case management" means a coordinated set of activities conducted for individual patient
9 management of serious, complicated, protracted, or otherwise complex health conditions.
10 (5) "Certification" means a determination by a health insurance issuer or its designated utilization
11 review organization that an admission, availability of care, continued stay, or other health care service has been
12 reviewed and, based on the information provided, satisfies the health insurance issuer's requirements for
13 medical necessity, appropriateness, health care setting, level of care, and level of effectiveness.
14 (6) "Chronic condition" means a condition that lasts 1 year or more and requires ongoing medical
15 attention or limits activities of daily living.
16 (6)(7) "Clinical peer" means a physician or other health care provider who:
17 (a) holds a nonrestricted license in a state of the United States; and
18 (b) is trained or works in the same or a similar specialty to the specialty that typically manages the
19 medical condition, procedure, or treatment under review.
20 (7)(8) "Clinical review criteria" means the written policies, written screening procedures, decision
21 abstracts, determination rules, clinical and medical protocols, practice guidelines, or any other criteria or
22 rationale used by a health insurance issuer or its designated utilization review organization to determine the
23 medical necessity of health care services.
24 (8)(9) "Concurrent review" means a utilization review conducted during a patient's stay or course of
25 treatment in a facility, the office of a health care professional, or another inpatient or outpatient health care
26 setting.
27 (9)(10) "Cost sharing" means the share of costs that a covered member pays under the health
- 2 - Authorized Print Version – SB 447

Amendment - 1st Reading/2nd House-blue - Requested by: Vince Ricci - (H) Business and
Labor
- 2025
69th Legislature 2025 Drafter: Jameson Walker, SB0447.002.001
1 insurance issuer's health plan, including maximum out-of-pocket, deductibles, coinsurance, copayments, or
2 similar charges, but does not include premiums, balance billing amounts for out-of-network providers, or the
3 cost of noncovered services.
4 (10)(11)"Covered benefits" or "benefits" means those health care services to which a covered person is
5 entitled under the terms of a health plan.
6 (11)(12)"Covered person" means a policyholder, a certificate holder, a member, a subscriber, an
7 enrollee, or another individual participating in a health plan.
8 (12)(13)"Discharge planning" means the formal process for determining, prior to discharge from a
9 facility, the coordination and management of the care that a patient receives after discharge from a facility.
10 (13)(14)"Emergency medical condition" has the meaning provided in 33-36-103.
11 (14)(15)"Emergency services" has the meaning provided in 33-36-103.
12 (15)(16)"External review" describes the set of procedures provided for in Title 33, chapter 32, part 4.
13 (16)(17)"Final adverse determination" means an adverse determination involving a covered benefit that
14 has been upheld by a health insurance issuer or its designated utilization review organization at the completion
15 of the health insurance issuer's internal grievance process as provided in Title 33, chapter 32, part 3.
16 (17)(18)"Grievance" means a written complaint or an oral complaint if the complaint involves an urgent
17 care request submitted by or on behalf of a covered person regarding:
18 (a) availability, delivery, or quality of health care services, including a complaint regarding an
19 adverse determination made pursuant to utilization review;
20 (b) claims payment, handling, or reimbursement for health care services; or
21 (c) matters pertaining to the contractual relationship between a covered person and a health
22 insurance issuer.
23 (18)(19)"Health care provider" or "provider" means a person, corporation, facility, or institution licensed
24 by the state to provide, or otherwise lawfully providing, health care services, including but not limited to:
25 (a) a physician, physician assistant, advanced practice registered nurse, health care facility as
26 defined in 50-5-101, osteopath, dentist, nurse, optometrist, chiropractor, podiatrist, physical therapist,
27 psychologist, licensed social worker, speech pathologist, audiologist, licensed addiction counselor, or licensed
- 3 - Authorized Print Version – SB 447

Amendment - 1st Reading/2nd House-blue - Requested by: Vince Ricci - (H) Business and
Labor
- 2025
69th Legislature 2025 Drafter: Jameson Walker, SB0447.002.001
1 professional counselor; and
2 (b) an officer, employee, or agent of a person described in subsection (18)(a) (19)(a) acting in the
3 course and scope of employment.
4 (19)(20)"Health care services" means services for the diagnosis, prevention, treatment, cure, or relief of
5 a health condition, illness, injury, or disease, including the provision of pharmaceutical products or services or
6 durable medical equipment.
7 (20)(21)"Health insurance issuer" has the meaning provided in 33-22-140.
8 (21)(22)"Medical necessity" means health care services that a health care provider exercising prudent
9 clinical judgment would provide to a patient for the purpose of preventing, evaluating, diagnosing, treating,
10 curing, or relieving a health condition, chronic condition, illness, injury, or disease or its symptoms or
11 comorbidities, including minimizing the progression, symptoms, or comorbidities of a health condition, chronic
12 condition, illness, injury, or disease, and that are:
13 (a) in accordance with generally accepted standards of practice;
14 (b) clinically appropriate in terms of type, frequency, extent, site, and duration and are considered
15 effective for the patient's illness, injury, or disease; and
16 (c) not primarily for the economic benefit of the insurer or convenience of the patient or health care
17 provider and not more costly than an alternative service or sequence of services at least as likely to produce
18 equivalent therapeutic or diagnostic results as to the diagnosis or treatment of the patient's illness, injury, or
19 disease.
20 (22)(23)"Network" means the group of participating providers providing services to a managed care
21 plan.
22 (23)(24)"Participating provider" means a health care provider who, under a contract with a health
23 insurance issuer or with its contractor or subcontractor, has agreed to provide health care services to covered
24 persons with the expectation of receiving payment, other than coinsurance, copayments, or deductibles, directly
25 or indirectly from the health insurance issuer.
26 (24)(25)"Person" means an individual, a corporation, a partnership, an association, a joint venture, a
27 joint stock company, a trust, an unincorporated organization, or any similar entity or combination of entities in
- 4 - Authorized Print Version – SB 447

Amendment - 1st Reading/2nd House-blue - Requested by: Vince Ricci - (H) Business and
Labor
- 2025
69th Legislature 2025 Drafter: Jameson Walker, SB0447.002.001
1 this subsection.
2 (25)(26)"Preservice claim" means a request for benefits or payment from a health insurance issuer for
3 health care services that, under the terms of the health insurance issuer's contract of coverage, requires
4 authorization from the health insurance issuer or from the health insurance issuer's designated utilization review
5 organization prior to receiving the services.
6 (26)(27)"Prospective review" means a utilization review, MEDICAL NECESSITY REVIEW, OR PRIOR
7 AUTHORIZATION conducted of a preservice claim prior to an admission or a course of treatment.
8 (27)(28)(a) "Rescission" means a cancellation or the discontinuance of coverage under a health plan
9 that has a retroactive effect.
10 (b) The term does not include a cancellation or discontinuance under a health plan if the
11 cancellation or discontinuance of coverage:
12 (i) has only a prospective effect; or
13 (ii) is effective retroactively to the extent that the cancellation or discontinuance is attributable to a
14 failure to timely pay required premiums or contributions toward the cost of coverage.
15 (28)(29)(a) "Retrospective review" means a review of medical necessity conducted after services have
16 been provided to a covered person.
17 (b) The term does not include the review of a claim that is limited to an evaluation of
18 reimbursement levels, veracity of documentation, accuracy of coding, or adjudication for payment.
19 (29)(30)"Second opinion" means an opportunity or requirement to obtain a clinical evaluation by a
20 health care provider other than the one originally making a recommendation for a proposed health care service
21 to assess the clinical necessity and appropriateness of the initial proposed health care service.
22 (30)(31)"Stabilize" means, with respect to an emergency condition, to ensure that no material
23 deterioration of the condition is, within a reasonable medical probability, likely to result from or occur during the
24 transfer of the individual from a facility.
25 (31)(32)(a) "Urgent care request" means a request for a health care service or course of treatment with
26 respect to which the time periods for making a nonurgent care request determination could:
27 (i) seriously jeopardize the life or health of the covered person or the ability of the covered person
- 5 - Authorized Print Version – SB 447

Amendment - 1st Reading/2nd House-blue - Requested by: Vince Ricci - (H) Business and
Labor
- 2025
69th Legislature 2025 Drafter: Jameson Walker, SB0447.002.001
1 to regain maximum function; or
2 (ii) subject the covered person, in the opinion of a health care provider with knowledge of the
3 covered person's medical condition, to severe pain that cannot be adequately managed without the health care
4 service or treatment that is the subject of the request.
5 (b) Except as provided in subsection (31)(c) (32)(c), in determining whether a request is to be
6 treated as an urgent care request, an individual acting on behalf of the health insurance issuer shall apply the
7 judgment of a prudent lay person who possesses an average knowledge of health and medicine.
8 (c) Any request that a health care provider with knowledge of the covered person's medical
9 condition determines is an urgent care request within the meaning of subsection (31)(a) (32)(a) must be treated
10 as an urgent care request.
11 (32)(33)"Utilization review" means a set of formal techniques designed to monitor the use of or to
12 evaluate the clinical necessity, appropriateness, efficacy, or efficiency of health care services, procedures, or
13 settings. Techniques may include ambulatory review, prospective review, second opinions, certification,
14 concurrent review, case management, discharge planning, or retrospective review.
15 (33)(34)"Utilization review organization" means an entity that conducts utilization review for one or
16 more of the following:
17 (a) an employer with employees who are covered under a health benefit plan or health insurance
18 policy;
19 (b) a health insurance issuer providing review for its own health plans or for the health plans of
20 another health insurance issuer;
21 (c) a preferred provider organization or health maintenance organization; and
22 (d) any other individual or entity that provides, offers to provide, or administers hospital, outpatient,
23 medical, or other health benefits to a person treated by a health care provider under a policy, plan, or contract."
24
25 Section 2. Section 33-32-107, MCA, is amended to read:
26 "33-32-107. Length of prior authorization. (1) A Except as provided in subjection (2), certification by
27 a utilization review organization approving health care services is valid for at least 3 12 months from the date
- 6 - Authorized Print Version – SB 447

Amendment - 1st Reading/2nd House-blue - Requested by: Vince Ricci - (H) Business and
Labor
- 2025
69th Legislature 2025 Drafter: Jameson Walker, SB0447.002.001
1 the health care provider receives the certification unless the covered person loses coverage under the
2 applicable health plan or health insurance coverage.
3 (2) A certification by a utilization review organization approving a health care service for treatment
4 of a chronic condition is valid for the duration of the condition. The utilization review organization may not
5 require the covered person to obtain certification again for the same health care service. The utilization review
6 organization may require documentation that the chronic condition remains present no more frequently than
7 every 12 months."
8
9 Section 3. Section 33-32-221, MCA, is amended to read:
10 "33-32-221. Prior authorization requirements. (1) A health insurance issuer or an entity that a
11 health insurance issuer IT contracts with to perform a prior authorization on the health insurance issuer's ITS
12 behalf may not perform prior authorization on benefits for:
13 (a) any generic prescription drug that is not listed within any of the schedules of controlled
14 substances found at 21 CFR 1308.11 through 21 CFR 1308.15 or the schedules of controlled substances found
15 in Title 50, chapter 32, after a covered person has been prescribed the covered drug at the same quantity
16 without interruption for 6 months;
17 (b) any prescription drug or drugs, generic or brand name, on the grounds of therapeutic
18 duplication for the same drug if the covered person has already been subject to prior authorization on the
19 grounds of therapeutic duplication for the same dosage of the prescription drug or drugs and coverage of the
20 prescription drug or drugs was approved;
21 (c) any prescription drug, generic or brand name, solely because the dosage of the medication for
22 the covered person has been adjusted by the prescriber of the prescription drug, as long as the dosage is
23 within the dosage approved by the food and drug administration or is consistent with clinical dosing for the
24 medication; or
25 (d) any prescription drug, generic or brand name, that is a long-acting injectable antipsychotic;
26 (e) controlled substances found at 21 CFR 1308.15 or the schedules of controlled substances
27 found in Title 50, chapter 32 AND ANY FORMULARY ORAL OR INHALED NONBIOLOGIC GENERIC PRESCRIPTION DRUG
- 7 - Authorized Print Version – SB 447

Amendment - 1st Reading/2nd House-blue - Requested by: Vince Ricci - (H) Business and
Labor
- 2025
69th Legislature 2025 Drafter: Jameson Walker, SB0447.002.001
1 THAT IS NOT LISTED AS A SPECIALTY TIER DRUG BY MEDICARE PART D, OR WITHIN ANY OF THE SCHEDULES OF
2 CONTROLLED SUBSTANCES FOUND AT 21 CFR 1308.11 THROUGH 21 CFR 1308.15 OR THE SCHEDULES OF
3 CONTROLLED SUBSTANCES FOUND IN TITLE 50, CHAPTER 32;
4 (f)(E) any prescription drug, generic or brand name, prescribed for treatment of a substance use
5 disorder, provided that the prescription does not exceed the U.S. food and drug administration labeled dosages;
6 or
7 (g)(F) AT LEAST ONE PRESCRIPTION DRUG OPTION APPROPRIATE FOR CHILDREN AND ONE APPROPRIATE FOR
8 ADULTS, WITHIN EACH any of the following prescription drugsDRUG THERAPEUTIC CLASSES, generic or brand name,
9 except as provided in subsection (3):
10 (i) an inhaled corticosteroid;
11 (ii) an inhaled short-acting beta-agonist;
12 (iii) an inhaled combination corticosteroid and beta-agonist;
13 (iv) a short-acting insulin for diabetes; or
14 (v) a long-acting insulin for diabetes.
15 (3) If an individual has multiple prescriptions for any one kind of prescription drug listed under
16 subsection (1)(g), a health insurance issuer or its utilization review organization may perform a prior
17 authorization on all but one prescription.
18 (4)(3) If the health insurance issuer or its utilization review organization makes an adverse
19 determination for a prescription drug during prior authorization, the health insurance issuer or its utilization
20 review organization shall provide a written adverse determination notice that includes a list of reasonable
21 therapeutic alternatives that are covered by the insurer's formulary.
22 (2)(5)(4) Any adverse determination for a prescription drug made during prior authorization by a
23 health insurance issuer must be made by a physician whose specialty focuses on the diagnosis and treatment
24 of the condition for which the prescription drug was prescribed to treat, provided that prior authorization that
25 does not result in an adverse determination does not require the involvement of a physician on the part of a
26 health insurance issuer."
27
- 8 - Authorized Print Version – SB 447

Amendment - 1st Reading/2nd House-blue - Requested by: Vince Ricci - (H) Business and
Labor
- 2025
69th Legislature 2025 Drafter: Jameson Walker, SB0447.002.001
1 COORDINATION SECTION. Section 4. Coordination instruction. If both House Bill No. 398 and
2 [this act] are passed and approved and if both contain a section that amends 33-22-102, then the sections
3 amending 33-22-102 are void and 33-22-102 must be amended as follows:
4 "33-32-102. Definitions. As used in this chapter, the following definitions apply:
5 (1) "Adverse determination", except as provided in 33-32-402, means:
6 (a) a determination by a health insurance issuer or its designated utilization review organization
7 that, based on the provided information and after application of any utilization review technique, a requested
8 benefit under the health insurance issuer's health plan is denied, reduced, or terminated or that payment is not
9 made in whole or in part for the requested benefit because the requested benefit does not meet the health
10 insurance issuer's requirement for medical necessity, appropriateness, health care setting, level of care, or level
11 of effectiveness or is determined to be experimental or investigational;
12 (b) a denial, reduction, termination, or failure to provide or make payment in whole or in part for a
13 requested benefit based on a determination by a health insurance issuer or its designated utilization review
14 organization of a person's eligibility to participate in the health insurance issuer's health plan;
15 (c) any prospective review or retrospective review of a benefit determination that denies, reduces,
16 or terminates or fails to provide or make payment in whole or in part for a benefit; or
17 (d) a rescission of coverage determination.
18 (2) "Ambulatory review" means a utilization review of health care services performed or provided in
19 an outpatient setting.
20 (3) "Authorized representative" means:
21 (a) a person to whom a covered person has given express written consent to represent the
22 covered person;
23 (b) a person authorized by law to provided substituted consent for a covered person; or
24 (c) a family member of the covered person, or the covered person's treating health care provider,
25 only if the covered person is unable to provide consent.
26 (4) "Case management" means a coordinated set of activities conducted for individual patient
27 management of serious, complicated, protracted, or otherwise complex health conditions.
- 9 - Authorized Print Version – SB 447

Amendment - 1st Reading/2nd House-blue - Requested by: Vince Ricci - (H) Business and
Labor
- 2025
69th Legislature 2025 Drafter: Jameson Walker, SB0447.002.001
1 (5) "Certification" means a determination by a health insurance issuer or its designated utilization
2 review organization that an admission, availability of care, continued stay, or other health care service has been
3 reviewed and, based on the information provided, satisfies the health insurance issuer's requirements for
4 medical necessity, appropriateness, health care setting, level of care, and level of effectiveness.
5 (6) "Chronic condition" means a condition that lasts 1 year or more and that requires ongoing
6 medical attention or limits activities of daily living.
7 (6)(7) "Clinical peer" means a physician or other health care provider who:
8 (a) holds a nonrestricted license in a state of the United States; and
9 (b) is trained or works in the same or a similar specialty to the specialty that typically manages the
10 medical condition, procedure, or treatment under review.
11 (7)(8) "Clinical review criteria" means the written policies, written screening procedures, decision
12 abstracts, determination rules, clinical and medical protocols, practice guidelines, or any other criteria or
13 rationale used by a health insurance issuer or its designated utilization review organization to determine the
14 medical necessity of health care services.
15 (8)(9) "Concurrent review" means a utilization review conducted during a patient's stay or course of
16 treatment in a facility, the office of a health care professional, or another inpatient or outpatient health care
17 setting.
18 (9)(10) "Cost sharing" means the share of costs that a covered member pays under the health
19 insurance issuer's health plan, including maximum out-of-pocket, deductibles, coinsurance, copayments, or
20 similar charges, but does not include premiums, balance billing amounts for out-of-network providers, or the
21 cost of noncovered services.
22 (10)(11)"Covered benefits" or "benefits" means those health care services to which a covered person is
23 entitled under the terms of a health plan.
24 (11)(12)"Covered person" means a policyholder, a certificate holder, a member, a subscriber, an
25 enrollee, or another individual participating in a health plan.
26 (12)(13)"Discharge planning" means the formal process for determining, prior to discharge from a
27 facility, the coordination and management of the care that a patient receives after discharge from a facility.
- 10 - Authorized Print Version – SB 447

Amendment - 1st Reading/2nd House-blue - Requested by: Vince Ricci - (H) Business and
Labor
- 2025
69th Legislature 2025 Drafter: Jameson Walker, SB0447.002.001
1 (13)(14)"Emergency medical condition" has the meaning provided in 33-36-103.
2 (14)(15)"Emergency services" has the meaning provided in 33-36-103.
3 (15)(16)"External review" describes the set of procedures provided for in Title 33, chapter 32, part 4.
4 (16)(17)"Final adverse determination" means an adverse determination involving a covered benefit that
5 has been upheld by a health insurance issuer or its designated utilization review organization at the completion
6 of the health insurance issuer's internal grievance process as provided in Title 33, chapter 32, part 3.
7 (17)(18)"Grievance" means a written complaint or an oral complaint if the complaint involves an urgent
8 care request submitted by or on behalf of a covered person regarding:
9 (a) availability, delivery, or quality of health care services, including a complaint regarding an
10 adverse determination made pursuant to utilization review;
11 (b) claims payment, handling, or reimbursement for health care services; or
12 (c) matters pertaining to the contractual relationship between a covered person and a health
13 insurance issuer.
14 (18)(19)"Health care provider" or "provider" means a person, corporation, facility, or institution licensed
15 by the state to provide, or otherwise lawfully providing, health care services, including but not limited to:
16 (a) a physician, physician assistant, advanced practice registered nurse, health care facility as
17 defined in 50-5-101, osteopath, dentist, nurse, optometrist, chiropractor, podiatrist, physical therapist,
18 psychologist, licensed social worker, speech pathologist, audiologist, licensed addiction counselor, or licensed
19 professional counselor; and
20 (b) an officer, employee, or agent of a person described in subsection (18)(a) (19)(a) acting in the
21 course and scope of employment.
22 (19)(20)"Health care services" means services for the diagnosis, prevention, treatment, cure, or relief of
23 a health condition, illness, injury, or disease, including the provision of pharmaceutical products or services or
24 durable medical equipment.
25 (20)(21)"Health insurance issuer" has the meaning provided in 33-22-140.
26 (21)(22)"Medical necessity" means health care services that a health care provider exercising prudent
27 clinical judgment would provide to a patient for the purpose of preventing, evaluating, diagnosing, treating,
- 11 - Authorized Print Version – SB 447

Amendment - 1st Reading/2nd House-blue - Requested by: Vince Ricci - (H) Business and
Labor
- 2025
69th Legislature 2025 Drafter: Jameson Walker, SB0447.002.001
1 curing, or relieving a health condition, chronic condition, illness, injury, or disease or its symptoms or
2 comorbidities, including minimizing the progression, symptoms, or comorbidities of a health condition, chronic
3 condition, illness, injury, or disease, and that are:
4 (a) in accordance with generally accepted standards of practice;
5 (b) clinically appropriate in terms of type, frequency, extent, site, and duration and are considered
6 effective for the patient's illness, injury, or disease; and
7 (c) not primarily for the economic benefit of the insurer or the convenience of the patient or health
8 care provider and not more costly than an alternative service or sequence of services at least as likely to
9 produce equivalent therapeutic or diagnostic results as to the diagnosis or treatment of the patient's illness,
10 injury, or disease.
11 (22)(23)"Network" means the group of participating providers providing services to a managed care
12 plan.
13 (23)(24)"Participating provider" means a health care provider who, under a contract with a health
14 insurance issuer or with its contractor or subcontractor, has agreed to provide health care services to covered
15 persons with the expectation of receiving payment, other than coinsurance, copayments, or deductibles, directly
16 or indirectly from the health insurance issuer.
17 (24)(25)"Person" means an individual, a corporation, a partnership, an association, a joint venture, a
18 joint stock company, a trust, an unincorporated organization, or any similar entity or combination of entities in
19 this subsection.
20 (25)(26)"Preservice claim" means a request for benefits or payment from a health insurance issuer for
21 health care services that, under the terms of the health insurance issuer's contract of coverage, requires
22 authorization from the health insurance issuer or from the health insurance issuer's designated utilization review
23 organization prior to receiving the services.
24 (26)(27)"Prospective review" means a utilization review, medical necessity review, or prior authorization
25 conducted of a preservice claim prior to an admission or a course of treatment.
26 (27)(28)(a) "Rescission" means a cancellation or the discontinuance of coverage under a health plan
27 that has a retroactive effect.
- 12 - Authorized Print Version – SB 447

Amendment - 1st Reading/2nd House-blue - Requested by: Vince Ricci - (H) Business and
Labor
- 2025
69th Legislature 2025 Drafter: Jameson Walker, SB0447.002.001
1 (b) The term does not include a cancellation or discontinuance under a health plan if the
2 cancellation or discontinuance of coverage:
3 (i) has only a prospective effect; or
4 (ii) is effective retroactively to the extent that the cancellation or discontinuance is attributable to a
5 failure to timely pay required premiums or contributions toward the cost of coverage.
6 (28)(29)(a) "Retrospective review" means a review of medical necessity conducted after services have
7 been provided to a covered person.
8 (b) The term does not include the review of a claim that is limited to an evaluation of
9 reimbursement levels, veracity of documentation, accuracy of coding, or adjudication for payment.
10 (29)(30)"Second opinion" means an opportunity or requirement to obtain a clinical evaluation by a
11 health care provider other than the one originally making a recommendation for a proposed health care service
12 to assess the clinical necessity and appropriateness of the initial proposed health care service.
13 (30)(31)"Stabilize" means, with respect to an emergency condition, to ensure that no material
14 deterioration of the condition is, within a reasonable medical probability, likely to result from or occur during the
15 transfer of the individual from a facility.
16 (31)(32)(a) "Urgent care request" means a request for a health care service or course of treatment with
17 respect to which the time periods for making a nonurgent care request determination could:
18 (i) seriously jeopardize the life or health of the covered person or the ability of the covered person
19 to regain maximum function; or
20 (ii) subject the covered person, in the opinion of a health care provider with knowledge of the
21 covered person's medical condition, to severe pain that cannot be adequately managed without the health care
22 service or treatment that is the subject of the request.
23 (b) Except as provided in subsection (31)(c) (32)(c), in determining whether a request is to be
24 treated as an urgent care request, an individual acting on behalf of the health insurance issuer shall apply the
25 judgment of a prudent lay person who possesses an average knowledge of health and medicine.
26 (c) Any request that a health care provider with knowledge of the covered person's medical
27 condition determines is an urgent care request within the meaning of subsection (31)(a)(32)(a) must be treated
- 13 - Authorized Print Version – SB 447

Amendment - 1st Reading/2nd House-blue - Requested by: Vince Ricci - (H) Business and
Labor
- 2025
69th Legislature 2025 Drafter: Jameson Walker, SB0447.002.001
1 as an urgent care request.
2 (32)(33)"Utilization review" means a set of formal techniques designed to monitor the use of or to
3 evaluate the clinical necessity, appropriateness, efficacy, or efficiency of health care services, procedures, or
4 settings. Techniques may include ambulatory review, prospective review, second opinions, certification,
5 concurrent review, case management, discharge planning, or retrospective review.
6 (33)(34)"Utilization review organization" means an entity that conducts utilization review for one or
7 more of the following:
8 (a) an employer with employees who are covered under a health benefit plan or health insurance
9 policy;
10 (b) a health insurance issuer providing review for its own health plans or for the health plans of
11 another health insurance issuer;
12 (c) a preferred provider organization or health maintenance organization; and
13 (d) any other individual or entity that provides, offers to provide, or administers hospital, outpatient,
14 medical, or other health benefits to a person treated by a health care provider under a policy, plan, or contract."
15
16 COORDINATION SECTION. Section 5. Coordination instruction. (1) If both House Bill 398 and
17 [this act] are passed and approved and if both contain a section that amends 33-22-107, then [section 4 of
18 House Bill No. 398], amending 33-32-107, is void.
19 (2) If both House Bill No. 399 and [this act] are passed and approved and if both contain a section
20 that amends 33-22-221, then [section 3 of this act], amending 33-22-221, is void.
21
22 - END -
- 14 - Authorized Print Version – SB 447

[DELETED:  D S- SIAEACD0B2S3" D4()"5()a6t7b8m9i0o1()a2r3o4()a5o6()a7()"]
[DELETED:  D S- a()"()ac()a()ao()"m0()"1r2r3m4()"5a6()"7()h8()i9m0()"1a2r3m4()"5t6s7()"]
[DELETED:  D S- isc(e(e(f0(1(2(3(4h5o6(7c8()a9a0()c1()m2i3(4b5()a6d7p]
[DELETED:  D S- p()ac(ad((c0c1c2c3()i4()c5e6()n7p8e9d0(1p2(3i4p5o6(7j]
[DELETED:  D S- t(hao(,W  (t0()T1c2()h3()i4f5(6b7()T8r9(0h1t2(3d4t5(6r7()s]
[DELETED:  D S- t()scs()Etj()Ac0a1(2e3s4c5(6m7()a8p9()a0a1()a2()a3m5S6" L7a]
[DELETED:  D S- ta()AoroeS0" P1h  sT 2b3()a4s5i6w7()a8d9g0p1()a2t3w4m5()a6() 7f    DAYFYORI]
[DELETED:  D S- MPD  E A ORW21CR1121CR15        RTT5,3 I  (()ado((A,as ,S  DGTe0()a1()a2()a3()a4()a5()I6s7a8()I9d0r1t2()A3h4o5d6h]
[DELETED:  D S- C C[a" D()"()atbm0i1o2()a3r4o5()a6o7()a8()"9a0()"1()a2c3()a4()a5o6()"7m]
[DELETED:  D S- ()"rrm()"m()"()h()i0m1()"2a3r4m5()"6t7s8()"9i0s1c2(3e4(5e6(7f]
[DELETED:  D S- ((((ho(c()a0a1()c2()m3i4(5b6()a7d8p9p0()a1c2(3a4d5(6(7c]
[DELETED:  D S- ccc()i()ce()ncp0i1(2p3(4i5p6o7(8j9t0(1h2a3o4(5c6(7t]
[DELETED:  D S- ()Tc()h()if(b()Tr0(1h2t3(4d5t6(7r8()s9t0()s1c2s3()E4t5j6()A7c]
[DELETED:  D S- a(esc(m()ap0()a1a2()a3()a4m6C C7[8H9()I0t2-]